Inspira Technologies OXY B.H.N (IINNW) Amortization (2022 - 2023)

Inspira Technologies OXY B.H.N's (IINNW) quarterly Amortization came in at $2.0 billion in Q2 2023, little changed quarter-over-quarter from $2.0 billion in Q4 2022.

Inspira Technologies OXY B.H.N (IINNW) Amortization (2022 - 2023) Analysis & Trends

Inspira Technologies OXY B.H.N has disclosed Amortization across 2 years of filings, most recently posting $2.0 billion for Q2 2023.

  • Amortization for Q2 2023 came in at $2.0 billion, changed N/A year-over-year; the trailing twelve-month figure through Jun 2023 was $2.0 billion (changed N/A YoY), and the FY2022 annual result was $2.0 billion, changed N/A from the prior year.
  • Amortization came in at $2.0 billion for Q2 2023 at Inspira Technologies OXY B.H.N, roughly flat from $2.0 billion in the prior quarter.
  • In the past five years, Amortization ranged from a high of $2.0 billion in Q2 2023 to a low of $2.0 billion in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortization (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn -
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn -
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn -
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn -
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn -
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn -
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn -
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn -
10 Inspira Technologies OXY B.H.N - - - -

Historic Data

Download Data
DateValue
Jun 30, 2023 2.02 Bn
Jun 30, 2023 2.02 Bn
Dec 31, 2022 2.02 Bn
Dec 31, 2022 2.02 Bn